Vera Therapeutics Statistics

Total Valuation

VERA has a market cap or net worth of $2.87 billion. The enterprise value is $2.45 billion.

Market Cap	2.87B
Enterprise Value	2.45B

Important Dates

The last earnings date was Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

VERA has 63.93 million shares outstanding. The number of shares has increased by 22.89% in one year.

Current Share Class	63.93M
Shares Outstanding	63.93M
Shares Change (YoY)	+22.89%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	0.93%
Owned by Institutions (%)	82.79%
Float	44.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.19
P/TBV Ratio	7.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.21, with a Debt / Equity ratio of 0.19.

Current Ratio	12.21
Quick Ratio	11.96
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-36.03

Financial Efficiency

Return on equity (ROE) is -73.25% and return on invested capital (ROIC) is -41.18%.

Return on Equity (ROE)	-73.25%
Return on Assets (ROA)	-38.12%
Return on Invested Capital (ROIC)	-41.18%
Return on Capital Employed (ROCE)	-56.81%
Revenue Per Employee	n/a
Profits Per Employee	-$2.25M
Employee Count	112
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, VERA has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.22% in the last 52 weeks. The beta is 1.21, so VERA's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	-9.22%
50-Day Moving Average	30.27
200-Day Moving Average	25.26
Relative Strength Index (RSI)	80.97
Average Volume (20 Days)	1,869,923

Short Selling Information

The latest short interest is 9.96 million, so 15.58% of the outstanding shares have been sold short.

Short Interest	9.96M
Short Previous Month	9.26M
Short % of Shares Out	15.58%
Short % of Float	22.61%
Short Ratio (days to cover)	6.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-270.18M
Pretax Income	-251.94M
Net Income	-251.94M
EBITDA	-269.79M
EBIT	-270.18M
Earnings Per Share (EPS)	-$4.00

Full Income Statement

Balance Sheet

The company has $497.39 million in cash and $77.22 million in debt, giving a net cash position of $420.17 million or $6.57 per share.

Cash & Cash Equivalents	497.39M
Total Debt	77.22M
Net Cash	420.17M
Net Cash Per Share	$6.57
Equity (Book Value)	398.88M
Book Value Per Share	6.24
Working Capital	469.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$210.29 million and capital expenditures -$1.17 million, giving a free cash flow of -$211.47 million.

Operating Cash Flow	-210.29M
Capital Expenditures	-1.17M
Free Cash Flow	-211.47M
FCF Per Share	-$3.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.89%
Shareholder Yield	-22.89%
Earnings Yield	-8.78%
FCF Yield	-7.37%

Dividend Details

Analyst Forecast

The average price target for VERA is $63.13, which is 40.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$63.13
Price Target Difference	40.60%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1